Friday, August 20, 2010
New Drug Class Promising Against Breast Cancer with BRCA Mutations
An experimental drug called olaparib shows promise for women with breast cancer who carry BRCA1 and BRCA2 gene mutations.
An RSS feed for the weekly update of relevant headlines from TheBreastCareSite.com